Navigation Links
CardioFocus HeartLight™ Endoscopic Ablation System to be Featured at EHRA EUROPACE 2011
Date:6/22/2011

MARLBOROUGH, Mass., June 22, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today that its technology will be the subject of several scientific sessions at the upcoming European Heart Rhythm Association (EHRA) EUROPACE 2011 congress, June 26-29 in Madrid, Spain.

HeartLight EAS is a unique catheter ablation technology that incorporates an endoscope and illumination to provide physicians with direct visualization within a beating heart, in real time and without radiation. It features a compliant, dynamically adjustable balloon catheter for improved contact with the pulmonary vein (PV) ostium and utilizes laser energy for more efficient, precise ablation. Recent data has demonstrated that approximately 86% of PVs remained persistently isolated after three months following a single procedure with HeartLight EAS, with 65% of patients achieving durable freedom from AF.

"Clinical results with HeartLight EAS throughout Europe have been very promising, and we are excited to showcase our technology at EUROPACE, where catheter ablation will be a major conference topic," commented Stephen Sagon, President and CEO of CardioFocus, Inc. "We are encouraged by the adoption of the technology by numerous cardiology thought leaders, many of whom are presenting at this congress, and expect to broaden the use of the system in Europe as a new treatment option for atrial fibrillation patients."

The HeartLight technology will be featured in the following EUROPACE 2011 sessions:

  • Mini-Satellite Symposium"Pulmonary vein isolation for atrial fibrillation using the laser balloon endoscopic ablation system," Monday, June 27
    Chaired by Vivek Y. Reddy, MD, of Mount Sinai School of Medicine, New York, USA and featuring presentations by Claudio Tondo, MD, PhD, of Centro Cardiologico Monzino, Milan, Italy and Julian Chun, MD,
    '/>"/>

  • SOURCE CardioFocus, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
    2. CardioFocus Secures $5M Credit Facility with Silicon Valley Bank
    3. New Studies Support CardioFocus HeartLight™ Endoscopic Ablation Systems Notable Treatment Results for Paroxysmal Atrial Fibrillation
    4. New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
    5. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
    6. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
    7. Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients
    8. Envisionier Announces the Launch of the endogo(R) HD, a Mobile Medical Imaging Platform for Capturing, Storing, and Sharing Endoscopic Multimedia
    9. ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement
    10. Reportlinker Adds Brazil, Russian, Indian and Chinese Markets for Endoscopic Devices 2009 (4 Countries)
    11. Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
    (Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
    (Date:5/22/2013)... May 22, 2013  The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...
    Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
    ... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®.  The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...
    ... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance).  The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...
    Cached Medicine Technology:The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 2New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 3New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 4New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 5New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 7New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 8New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 9New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 10
    (Date:5/23/2013)... California (PRWEB) May 23, 2013 According ... titled “SBU-Led Study Reveals Nanoparticles Found in Everyday Items ... found in everyday items such as cosmetics and other ... human body. As a result, men and women who ... means that they develop wrinkles earlier than ...
    (Date:5/23/2013)... Wei Angela Liu, MD, of Mamaroneck, NY, ... as Medical Director of Physical Medicine and ... rehabilitation care to patients of all ages and stages ... in biochemistry at Columbia College, honored as a Fu ... medical degree at New York University School of Medicine ...
    (Date:5/23/2013)... Diversity Focus announced today that in 2013 ... of diversity. The results come from the 2013 Creative ... of this year. 1198 qualified residents took part. The ... its benchmark survey in 2008. , In both 2008 ... of diversity were race and ethnicity. But the numbers ...
    (Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Mild to moderate ... impact on children,s brain development, British researchers report. ... expectant mother,s diet appear to put her child at ... preteen years, the study authors found. Pregnant women can ... and seafood, the researchers suggested. The finding, published ...
    (Date:5/23/2013)... By Steven Reinberg HealthDay Reporter , , THURSDAY, ... frequent heartburn may be at increased risk for cancers ... don,t smoke or drink alcohol, a new study says. ... these cancers while prescription medications such as Prilosec, Nexium ... been a controversy about whether heartburn contributes to cancers ...
    Breaking Medicine News(10 mins):Health News:Aging and Wrinkles – Gold Found in Everyday Products Can Accelerate the Visual Signs of Aging 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Diversity Focus Announces Results from the 2013 Creative Corridor Community Survey 2Health News:Low Prenatal Iodine May Affect Child's Brain Development 2Health News:Chronic Heartburn May Raise Odds for Throat Cancer: Study 2
    ... U.S.,Presidential candidate Hillary Clinton today pledged to expand the ... if elected, setting,the goal of ending malaria-related deaths in ... said this funding would be in addition to U.S.,government ... the Global,Fund to Fight AIDS, Tuberculosis, and Malaria, which ...
    ... Sumitomo Corporation of America,(SCOA) announced the appointment of ... animal healthcare company, Summit VetPharm, LLC. Mr.,Isohata joins ... 15,years as head of Sumitomo,s Household Insecticides and ... for the Petcare business,in the Life Science Division, ...
    ... their odds for cardiovascular disease , THURSDAY, Nov. ... cholesterol boosts their heart risks helps them stick ... at McGill University in Montreal enrolled more than ... problems who were instructed to change their lifestyle ...
    ... 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, ... called apoptosis plays a key role in development, and ... their work. As apoptotic cells degrade, they display standard ... fragmentation. , Now, Harvard Medical School researchers have uncovered ...
    ... million men and women in the United States live ... that permeates muscles in the neck, back and shoulders. ... understood, but research studies indicate that a new imaging ... definitive diagnosis and, perhaps eventually, new treatments for people ...
    ... adrenal masses are found incidentally during a CT scan, ... additional imaging follow-up, according to a recent study conducted ... , With increased utilization of CT, we are ... the patients were scanned, the so called incidentalomas, of ...
    Cached Medicine News:Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 2Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 3Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 2Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 3Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 4Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 5Health News:Knowing Heart Risk Keeps Patients on Cholesterol Drugs 2Health News:Homeless cells find temporary lodging -- and their demise 2Health News:Homeless cells find temporary lodging -- and their demise 3Health News:MRE could provide a definitive diagnosis for people with muscle pain, Mayo Clinic study shows 2
    Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
    Inquire...
    ... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
    ... PRISM 7000 Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... accumulated PCR product is made possible ... and application-specific software in a single ...
    Medicine Products: